Inventor · disambiguated record
Marco Emgenbroich
Also filed as: EMGENBROICH MARCO
13 granted patents·17 pending applications·4 citations·filing 2006–2023
82Inventor score
Top patents by PatentIndex Score
30 records- 0187US11576874B2Transdermal therapeutic system for the transdermal administration of guanfacine comprising a silicone polymerLTS LOHMANN THERAPIE SYSTEME AG·Filed 2018·Granted Feb 14, 2023·4 cites·17 claims
- 0273US12168074B2Transdermal therapeutic system for the transdermal administration of guanfacine comprising a silicone polymerLTS LOHMANN THERAPIE SYSTEME AG·Filed 2023·Granted Dec 17, 2024·0 cites·18 claims
- 0369US12070521B2Method for adjusting the release of active agent in a transdermal delivery systemLTS LOHMANN THERAPIE SYSTEME AG·Filed 2022·Granted Aug 27, 2024·0 cites·10 claims
- 0468US12427119B2Transdermal delivery system including an interface mediatorLTS LOHMANN THERAPIE SYSTEME AG·Filed 2023·Granted Sep 30, 2025·0 cites·19 claims
- 0567US2023248661A1Transdermal Delivery System Containing RotigotineLTS LOHMANN THERAPIE SYSTEME AG·Filed 2023·Application pending·0 cites
- 0662US2022151949A1Multi-Day Patch for the Transdermal Administration of RotigotineLTS LOHMANN THERAPIE SYSTEME AG·Filed 2022·Application pending·0 cites
- 0760US2025345268A1Oral thin filmLTS LOHMANN THERAPIE SYSTEME AG·Filed 2023·Application pending·0 cites
- 0859US2024374544A1Transdermal therapeutic system for the transdermal administration of guanfacine comprising guanfacine and a mono-carboxylic acidLTS LOHMANN THERAPIE SYSTEME AG·Filed 2022·Application pending·0 cites
- 0958US11389410B2Multi-day patch for the transdermal administration of rotigotineLTS LOHMANN THERAPIE SYSTEME AG·Filed 2013·Granted Jul 19, 2022·0 cites·27 claims
- 1057US2024285771A1Rapidly disintegrating oral thin-films/foams having a high active-ingredient content based on a mixture of polyvinyl alcohols having various molecular weightsLTS LOHMANN THERAPIE SYSTEME AG·Filed 2022·Application pending·0 cites
- 1153US11426359B2Method for adjusting the release of active agent in a transdermal delivery systemLTS LOHMANN THERAPIE SYSTEME AG·Filed 2015·Granted Aug 30, 2022·0 cites·14 claims
- 1252US11198800B2Control of adhesive domainsLTS LOHMANN THERAPIE SYSTEME AG·Filed 2017·Granted Dec 14, 2021·0 cites·18 claims
- 1350US12214088B2Transdermal therapeutic system for the transdermal administration of guanfacine comprising at least one additiveLTS LOHMANN THERAPIE SYSTEME AG·Filed 2018·Granted Feb 4, 2025·0 cites·10 claims
- 1450US12048770B2Transdermal therapeutic system for the transdermal administration of guanfacine comprising a silicone acrylic hybrid polymerLTS LOHMANN THERAPIE SYSTEME AG·Filed 2018·Granted Jul 30, 2024·0 cites·25 claims
- 1550US11633367B2Transdermal delivery system containing rotigotineLTS LOHMANN THERAPIE SYSTEME AG·Filed 2015·Granted Apr 25, 2023·0 cites·38 claims
- 1650US2010203001A1Process for forming disulfide bridgesAPLAGEN GMBH·Filed 2007·Application pending·0 cites
- 1749US11752110B2Transdermal delivery system including an interface mediatorLTS LOHMANN THERAPIE SYSTEME AG·Filed 2015·Granted Sep 12, 2023·0 cites·7 claims
- 1849US2021000755A1Transdermal therapeutic system for the transdermal administration of buprenorphine comprising a silicone acrylic hybrid polymerLTS LOHMANN THERAPIE SYSTEME AG·Filed 2019·Application pending·0 cites
- 1948US2024398765A1Transdermal therapeutic system for the transdermal administration of tizanidineLTS LOHMANN THERAPIE SYSTEME AG·Filed 2022·Application pending·0 cites
- 2048US2022079887A1Transdermal therapeutic system with diffusion barrierLTS LOHMANN THERAPIE SYSTEME AG·Filed 2019·Application pending·0 cites
- 2148US2022096367A1Oral thin filmLTS LOHMANN THERAPIE SYSTEME AG·Filed 2020·Application pending·0 cites
- 2245US9329186B2Imprinted polymers with affinity for phosphorylated peptides and proteinsSELLERGREN BÖRJE·Filed 2008·Granted May 3, 2016·0 cites·9 claims
- 2345US2021052569A1Transdermal therapeutic system containing nicotine and silicone acrylic hybrid polymerLTS LOHMANN THERAPIE SYSTEME AG·Filed 2019·Application pending·0 cites
- 2443US2021008000A1Transdermal therapeutic system comprising a silicone acrylic hybrid polymerLTS LOHMANN THERAPIE SYSTEME AG·Filed 2019·Application pending·0 cites
- 2543US2021038532A1Transdermal therapeutic system comprising a silicone acrylic hybrid polymerLTS LOHMANN THERAPIE SYSTEME AG·Filed 2019·Application pending·0 cites
- 2643US2022241215A1Transdermal therapeutic system comprising an active agent-containing layer comprising a silicone-containing polymer and a skin contact layer comprising a silicone gel adhesiveLTS LOHMANN THERAPIE SYSTEME AG·Filed 2020·Application pending·0 cites
- 2741US11389421B2Transdermal therapeutic system for the transdermal administration of rivastigmineLTS LOHMANN THERAPIE SYSTEME AG·Filed 2018·Granted Jul 19, 2022·0 cites·15 claims
- 2838US2009081145A1Process for forming disulphide bridgesAPLAGEN GMBH·Filed 2006·Application pending·0 cites
- 2937US2022241216A1Transdermal therapeutic system comprising an active agent-containing layer comprising an acrylic polymer and a skin contact layer comprising a silicone gel adhesiveLTS LOHMANN THERAPIE SYSTEME AG·Filed 2020·Application pending·0 cites
- 3036US2021000756A1Transdermal therapeutic system comprising a silicone acrylic hybrid polymerLTS LOHMANN THERAPIE SYSTEME AG·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marco Emgenbroich files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →